If you're reading about american realty capital healthcare now, there's a good chance you're not doing it out of curiosity. You're trying to figure out what happened to an investment that was presented as stable, income-producing, and appropriate for a conservative account, but later became difficult to value, difficult to sell, or disappointing.

That reaction is justified. In practice, many investors who bought non-traded REITs were not really buying a simple real estate investment. They were buying a packaged product with limited liquidity, high selling costs, internal valuation issues, and in some cases serious conflicts of interest. When those features weren't explained clearly, the legal issue often isn't just market loss. It's whether the recommendation itself was unsuitable or misleading.

Understanding American Realty Capital Healthcare A Non-Traded REIT

A retiree sits down to review an account statement and sees a familiar problem. The investment was sold as healthcare real estate, income, and stability. Years later, the harder question is whether the structure itself made the investment far riskier than the sales pitch suggested.

American Realty Capital Healthcare Trust, Inc. was a non-traded REIT formed in 2010 to invest in healthcare real estate, with a focus that included medical office buildings and other healthcare-related properties. The company later assembled a large portfolio and ultimately entered a 2014 stock-and-cash transaction with Ventas valued at $11.33 per share, as described in the American Healthcare REIT investor overview.

That history matters, but the legal and financial analysis starts with the product type. A non-traded REIT does not trade on a public exchange like ordinary stock. An investor usually cannot sell quickly at a transparent market price. Value is often based on sponsor-directed processes, periodic estimates, and a future liquidity event rather than day-to-day market trading.

That gap between what investors expected and how the product played out is often the beginning of a recovery case.

For readers who want background on the structure itself, this explanation of non-traded real estate investment trust risks helps frame why these products create recurring suitability and disclosure issues.

What investors were actually buying

ARC Healthcare owned real real estate. That point is important because many investors assume a tangible asset base means lower risk. In practice, real properties do not solve liquidity problems, valuation opacity, or high upfront selling costs.

Healthcare properties also carry their own trade-offs. Medical office buildings and long lease terms can support steady income. They can also create a false sense of safety if the investor was never told that the shares might be difficult to sell, hard to value, or dependent on a later merger or listing to establish market value.

From a securities-law perspective, that distinction matters. A legitimate asset class can still be packaged and sold in a way that is unsuitable for a conservative investor, especially one who needed access to principal, clearer pricing, or lower-fee alternatives.

Why the non-traded structure mattered

Publicly traded REITs reprice every trading day. Non-traded REITs do not. That difference affects nearly every issue that later appears in an investor claim.

Limited liquidity is the practical problem investors feel first. If an account holder needed cash for medical expenses, living costs, or portfolio rebalancing, there often was no easy exit. Redemption programs, if available at all, were usually limited and subject to suspension or sponsor control.

Valuation is the second problem. Many investors saw account statements showing a share value and assumed that figure reflected a real market. Often it did not. In these cases, I look closely at whether the client understood who set the valuation, how often it changed, and whether that process was explained before the purchase.

The investor question that matters now

The central issue is not whether healthcare real estate was a reasonable investment theme. The issue is whether this specific non-traded REIT was recommended in a way that matched the investor's age, liquidity needs, risk tolerance, and concentration limits.

When I assess potential claims, I focus on three points:

• whether the investor was told how difficult it could be to sell the shares
• whether the valuation method was explained clearly enough to avoid a misleading impression of stability
• whether the recommendation made sense compared with publicly traded REITs, bonds, or other income investments with better liquidity and lower structural friction

Those facts do more than explain what happened. They also help build the record needed to pursue recovery.

Why Investors Lost Money Conflicts Of Interest And Misconduct

A retired investor opens a statement, sees a relatively steady share value, and assumes the investment is holding up. Months later, the actual problem becomes clear. The issue was never just real estate performance. It was a structure with conflicts, high friction, and sales practices that often left investors without a fair picture of the risk.

That distinction matters in recovery cases. Losses tied to american realty capital healthcare often trace back to how the product was built, how affiliated parties operated, and how brokers presented it to clients. For many investors, the strongest claim is not "the investment went down." It is "I was sold an illiquid, conflict-heavy product without a clear explanation of what could go wrong."

One of the recurring concerns involves affiliated relationships within the sponsor network. Blue Vault's discussion of ARC Healthcare Trust III describes the sponsor's management of multiple REITs and a sale between affiliated entities. In practice, that kind of arrangement raises a hard question. Were decisions made to serve shareholders, or to solve problems elsewhere in the sponsor family?

Conflicts of interest do not automatically establish fraud. They do, however, increase the need for clear disclosure, independent supervision, and a recommendation process that matches the product to the investor. If those protections break down, affiliated transactions can become evidence, not background.

How conflicts translated into investor harm

The harm usually showed up through pricing, timing, and control.

If the sponsor had influence over valuation methods or over transactions between related entities, investors could receive account statements that looked calmer than the underlying risk justified. That affects behavior. A client who believes the shares are holding value is less likely to ask questions, sell other positions to reduce exposure, or challenge the original recommendation.

I see this repeatedly in non-traded REIT matters. Reported stability can delay an investor's response long enough to make the eventual losses worse and the paper trail harder to reconstruct.

Fees and limited exit options made the problem worse

High front-end costs also put investors at a disadvantage from day one. As noted earlier in the article, the offering materials described substantial selling commissions and expenses, and repurchase programs with strict annual limits. Those features matter because they reduce the capital put to work and restrict an investor's ability to get out if concerns develop.

That is not a technical issue. It is a practical one. An investor who needs liquidity, or who learns later that the risks were not explained properly, may find that the structure itself blocks a prompt exit.

For readers comparing products or documenting what should have been reviewed before a recommendation, a real estate due diligence checklist is a useful way to frame the questions a broker should have addressed before client funds were committed.

Why advisor conduct is often the center of a legal claim

In many cases, the legal focus turns to the brokerage firm and financial advisor. That is where suitability, concentration, disclosure, and supervision issues usually live.

Common fact patterns include:

• recommending an illiquid non-traded REIT to a retiree or conservative investor who needed access to principal
• placing too much of the client's net worth into one sponsor, one product category, or one illiquid strategy
• failing to explain how conflicts between affiliated entities could affect pricing or transactions
• treating statement valuations as if they reflected a real market price
• emphasizing income potential while giving inadequate attention to fees, liquidity limits, and sponsor incentives

These points are not abstract. They are the building blocks of a recovery case. Account forms, notes from the sales meeting, concentration levels in the portfolio, and the language used to describe risk can all help show whether the recommendation was suitable.

Investors dealing with this kind of product often benefit from reviewing the broader warning signs discussed in this overview of non-traded REIT risks and investor claims.

What investors should focus on now

The most productive approach is to examine the recommendation record with precision.

That is the practical shift investors need to make. Recovery usually depends on proving what was said, what was omitted, and why the recommendation did not fit the client.

Spotting The Red Flags Warning Signs Of Risky Non-Traded REITs

A retiree sits across from a broker, hears "healthcare real estate," "income," and "stability," and signs the subscription documents without a clear explanation of how the investment can be sold, what the full costs are, or who benefits from the deal structure. That fact pattern shows up often in non-traded REIT cases, and it is exactly why red-flag review matters before and after a loss.

American Realty Capital Healthcare is a useful case study because the warning signs were not hidden in some technical corner. They were embedded in the product design and the sales process. Illiquidity, opaque pricing, layered fees, and sponsor-side conflicts can all exist in one offering. When that happens, the investor is taking more risk than the monthly account statement suggests.

As noted earlier, offering documents for products like this described substantial upfront costs and strict limits on repurchase programs. For an investor, that means two practical problems from day one. A material portion of the money may be consumed by selling costs and offering expenses, and access to the remaining capital may be sharply limited if circumstances change.

For readers reviewing other real estate programs, a practical real estate due diligence checklist helps frame the property-level questions. For the securities side, this guide to non-traded REIT risks and investor claims addresses the features that often matter most in suitability disputes.

Warning Signs of High-Risk Non-Traded REITs

Questions that expose the real risk

Investors do not need to master REIT underwriting to spot trouble. They do need clear answers.

• How do I sell this if I need funds next year, not ten years from now? A vague answer usually means liquidity is far more limited than the sales pitch suggests.
• Who determines the share price on my statement? If there is no public market, ask what method is used and whether that figure reflects an actual sale price.
• What total compensation is paid to the broker and the sponsor? The full cost structure matters because high selling expenses can weigh on performance from the start.
• How much of my net worth or liquid portfolio would be tied up here? Even a lawful product can become unsuitable if the concentration is too high.
• What other, more liquid options were considered? That question often exposes whether the recommendation was suited to the client or driven by product economics.

Investor checkpoint: If you cannot explain how valuation works and what restrictions apply to getting out, you do not yet have enough information to approve the investment.

What matters in a later recovery case

These red flags are not only screening tools. They are also evidence points.

If a broker emphasized steady income but gave little attention to illiquidity, concentration, or sponsor conflicts, that sales record may support claims based on unsuitability or misrepresentation. If the account was already concentrated, or if the client needed access to principal for retirement, healthcare, or living expenses, those facts become even more important. The practical question is whether the recommendation fit the investor's objectives, risk tolerance, liquidity needs, and financial circumstances.

That is why I tell investors to preserve the paper trail early. Keep account statements, subscription agreements, new account forms, emails, handwritten notes from meetings, and any brochures used during the sale. In non-traded REIT cases, the strongest claims are often built from ordinary documents that show what was promised, what was omitted, and how little room the investor had to exit once the money went in.

Legal Pathways For Recovering Your Investment Losses

If you lost money in an ARC Healthcare-related product, the legal question isn't just whether the investment declined. The key question is which recovery path fits the facts of your case.

For many investors in products like Healthcare Trust REIT, formerly ARC Healthcare Trust II, value erosion exceeded 80%, with shares trading at a fraction of their original offering price, and extensive data tracking success rates of FINRA arbitrations for these specific losses remains scarce, according to Wolper Law's discussion of Healthcare Trust REIT losses. That scarcity is one reason case-specific legal analysis matters. Generic internet answers usually aren't enough.

Investors looking at brokerage-firm claims should also understand the role of non-traded REIT dispute recovery options, especially when the issue is how the product was sold rather than just how it later performed.

FINRA arbitration

For most investors with brokerage account claims, FINRA arbitration is the main route. Brokerage account agreements often require disputes with the firm or advisor to be resolved there instead of in court.

The process is usually more focused than court litigation. The investor files a statement of claim, the firm responds, documents are exchanged, and the matter proceeds toward hearing or settlement. In practice, these cases often center on unsuitability, failure to disclose risks, overconcentration, negligent supervision, or breach of fiduciary duty where applicable.

Pros of FINRA arbitration

• Direct claim against the brokerage firm. That's often where recovery is most realistic.
• Case-specific relief. The claim is based on your account, your losses, and your advisor's conduct.
• Potentially faster than full court litigation. Timelines vary, but arbitration is often the more practical forum.

Cons of FINRA arbitration

• Discovery is narrower than in many court cases.
• Appeal rights are limited.
• Preparation still matters greatly. A poorly documented claim can underperform even if the facts are strong.

Most investors don't need a public scandal to bring a viable claim. They need evidence that the recommendation didn't fit their profile or that key risks weren't disclosed.

Securities class actions

A class action can sound appealing because many investors join one proceeding. But for losses tied to unsuitable recommendations, class actions are often not the best fit.

Why? Because suitability cases are personal. They turn on who recommended the product, what was said, what the account objectives were, what percentage of the portfolio was invested, and what the investor needed at the time. A class case usually focuses on broader issuer-level conduct, not the specifics of your brokerage relationship.

Class action advantages

• Lower day-to-day involvement from the investor.
• Broad claims can proceed without every investor litigating separately.

Class action drawbacks

• Recovery per investor may be limited.
• You have very little control.
• The case may not address the broker-specific misconduct that caused the loss in your account.

State court lawsuits

Sometimes state court is an option, especially where the defendant is not bound by FINRA arbitration, where there are related common-law claims, or where the case involves parties outside the brokerage agreement.

State court can offer broader procedures in some circumstances. But it can also mean more delay, more motion practice, and more cost pressure. For an individual investor pursuing a sales-practice case against a brokerage firm, arbitration is often still the more efficient route.

A side-by-side comparison

What usually works best

In practice, the strongest recovery path is often the one that ties your loss to concrete account-level facts. That includes risk tolerance, age, income needs, liquidity needs, concentration, and what the advisor did or failed to explain.

A legal strategy works best when it is built around documents, not frustration alone.

Your Action Plan Steps To Take Right Now

You open an account statement, see a position tied to American Realty Capital Healthcare, and realize the problem is no longer theoretical. The investment is illiquid, the pricing history is hard to follow, and the advisor who sold it may have described it as stable income or a conservative real estate holding. At that point, the goal is not to relive the sales pitch. The goal is to preserve evidence and evaluate whether the recommendation itself was improper.

Start with documents, not assumptions.

The strongest recovery cases usually connect the product's known trouble spots, including conflicts of interest, layered fees, illiquidity, and valuation problems, to what happened in your account. That requires records showing what you were told, what the firm knew about you, and whether the recommendation fit your needs at the time of sale.

Pull the file before records disappear

Gather and save copies of:

• Account statements showing the purchase date, size of the position, later account values, and any liquidation or transfer activity.
• New account forms and updates listing your investment objective, risk tolerance, age, income needs, net worth, and liquidity needs.
• Offering materials such as the prospectus, subscription documents, marketing brochures, and any illustrations used during the sale.
• Emails, text messages, letters, and handwritten notes reflecting what the broker or advisor said about income, safety, principal protection, exit options, or expected share value.
• Tax records and distribution history showing what you received and when.
• Any written complaint sent to the advisor, branch manager, or compliance department, along with the firm's response.

If you do not have a complete file, request it now. Broker communications and account records become harder to collect with time.

Write out the sales story while you still remember it

A useful case timeline is usually simple and specific. Dates matter. Exact words matter more than people expect.

Include these points:

1. When the investment was first recommended.
2. Why the advisor said it fit your account.
3. What you were told about liquidity, distributions, valuation, and risk.
4. Whether you were relying on the investment for retirement income or near-term cash needs.
5. When you first realized you could not sell easily, access principal, or trust the reported value.
6. Any later conversations where the advisor told you to keep holding or minimized the problem.

This timeline often becomes the backbone of a claim because it shows how the sale happened, not just how it ended.

Examine suitability in concrete terms

Investors often focus on the issuer's history alone. That is only part of the case. A broker can still be liable if the recommendation was unsuitable for your account even before the product's wider problems became obvious.

Ask direct questions:

• Was too much of your portfolio placed in this one non-traded REIT or in similar alternative investments?
• Did you need liquidity for retirement, medical costs, or living expenses?
• Were you told the investment was low risk, stable, or appropriate for preserving principal?
• Did the advisor discuss high fees, limited redemption options, and the difficulty of valuing a non-traded REIT?
• Were more liquid or less complex alternatives ignored?

Those facts help show whether the sale reflected your interests or the seller's incentives.

Do not guess at deadlines

Waiting hurts claims. It also creates avoidable fights over timeliness.

The filing window depends on the type of claim, the forum, the brokerage agreement, and when you discovered or reasonably should have discovered the misconduct. Investors should get case-specific advice early, especially if they are considering a claim through FINRA arbitration counsel for investment loss cases.

Put your losses in working form

You do not need a final damages calculation before speaking with counsel. You do need a usable summary.

Create a short loss worksheet with:

• total amount invested
• any distributions received
• any reinvested distributions or additional purchases
• current estimated value, if any, or liquidation proceeds
• fees, surrender charges, or transfer losses tied to the position

That gives counsel a starting point for analyzing damages and whether the economics of a claim justify formal action.

Use current evidence carefully

Investors sometimes look to later market commentary to explain what happened. That can help with context, but it does not replace account-level proof. For example, commentary about the successor entity's trading or real estate pressures may show that market headwinds continued after the original sale. If you rely on later material, identify its date clearly and treat it as background, not proof of misconduct at the time you invested.

Law firms handling these cases also rely on organized document review and chronology building. For readers interested in how that process is managed, this overview of best legal tech tools gives a useful look at the systems firms use to sort evidence efficiently.

One practical rule applies throughout. Save everything, write down what happened, and get the file reviewed before more time passes.

How Kons Law Can Help You Pursue A Claim

Claims involving american realty capital healthcare and similar non-traded REITs usually turn on a handful of recurring issues: unsuitability, overconcentration, failure to disclose illiquidity, misleading valuation expectations, and conflicts connected to the way the product was sold. These are fact-heavy cases. They require a careful review of account forms, statements, sales materials, and communications with the advisor.

Kons Law focuses on securities and investment litigation for investors who were harmed by broker or advisor misconduct. That includes claims involving non-traded REITs, FINRA arbitration, breach of fiduciary duty, and negligent supervision. If the core problem in your case is that the investment never fit your account in the first place, the legal analysis should begin there.

The firm also understands the practical barrier many investors face after a loss. They don't want to spend more money chasing a claim unless the case has real merit. That's why contingency-fee representation matters. It aligns the firm's incentive with the client's recovery.

For investors interested in how law firms organize complex document review and case preparation, this overview of best legal tech tools offers a useful look at the systems modern firms use to manage evidence efficiently. Investors considering arbitration can also review this page about working with a FINRA arbitration attorney.

If you would like a free consultation to discuss the investment loss recovery process in more detail, call Kons Law Firm at (860) 920-5181 for a FREE, NO OBLIGATION consultation.

If you believe you suffered losses because a broker or advisor improperly recommended american realty capital healthcare or a similar non-traded REIT, contact Kons Law to discuss your options. A focused review of your account records, sales materials, and advisor communications can help determine whether you may have a viable claim for recovery.